Hall Håkan, Velikyan Irina, Blom Elisabeth, Ulin Johan, Monazzam Azita, Påhlman Lars, Micke Patrick, Wanders Alkwin, McBride William, Goldenberg David M, Långström Bengt
Department of Medicinal Chemistry, Preclinical PET Platform, Uppsala University Uppsala, Sweden.
Am J Nucl Med Mol Imaging. 2012;2(2):141-50. Epub 2012 Mar 28.
The carcinoembryonic antigen (CEA) was visualized in vitro in tissue from patients with colorectal cancer with trivalent bispecific antibody TF2 and two hapten molecules, [(67/68)Ga]Ga-IMP461 and [(67/68)Ga]Ga-IMP485 by means of pretargeting. Colorectal cancer tissue samples obtained from surgery at Uppsala University Hospital, were frozen fresh and cryosectioned. The two hapten molecules comprising 1,4,7-triazacyclononanetriacetic acid chelate moiety (NOTA) were labeled with (67)Ga or (68)Ga. The autoradiography was conducted by incubating the tissue samples with the bispecific antibody TF2, followed by washing and incubation with one of the radiolabeled hapten molecules. After washing, drying and exposure to phosphor imager plates, the autoradiograms were analyzed and compared to standard histochemistry (hematoxylin-eosin). Pronounced binding was found in the tissue from colorectal cancer using the bispecific antibody TF2 and either of the haptens [(67/68)Ga]Ga-IMP461 and [(67/68)Ga]Ga-IMP485. Distinct binding was also detected in the epithelium of most samples of neighboring tissue, taken at a minimum of 10 cm from the site of the tumor. It is concluded that pretargeting CEA with the bispecific antibody TF2 followed by the addition of (67/68)Ga-labeled hapten is extremely sensitive for visualizing this marker for colorectal cancer. This methodology is therefore a very specific complement to other histochemical techniques in the diagnosis of biopsies or in samples taken from surgery. Use of the pretargeting technique in vivo may also be an advance in diagnosing patients with colorectal cancer, either using (67)Ga and SPECT or (68)Ga and PET.
通过预靶向技术,利用三价双特异性抗体TF2以及两种半抗原分子[(67/68)Ga]Ga-IMP461和[(67/68)Ga]Ga-IMP485,在体外对结直肠癌患者的组织中的癌胚抗原(CEA)进行了可视化。从乌普萨拉大学医院手术获取的结直肠癌组织样本,新鲜冷冻后进行冰冻切片。包含1,4,7-三氮杂环壬烷三乙酸螯合部分(NOTA)的两种半抗原分子用(67)Ga或(68)Ga进行标记。通过将组织样本与双特异性抗体TF2孵育,随后洗涤并与其中一种放射性标记的半抗原分子孵育来进行放射自显影。洗涤、干燥并暴露于磷光成像板后,分析放射自显影片并与标准组织化学(苏木精-伊红)进行比较。使用双特异性抗体TF2以及半抗原[(67/68)Ga]Ga-IMP461和[(67/68)Ga]Ga-IMP485中的任何一种,在结直肠癌组织中均发现了明显的结合。在距离肿瘤部位至少10厘米处获取的大多数相邻组织样本的上皮中也检测到了明显的结合。结论是,用双特异性抗体TF2预靶向CEA后添加(67/68)Ga标记的半抗原对于可视化结直肠癌的这一标志物极其敏感。因此,该方法是活检诊断或手术样本诊断中对其他组织化学技术的一种非常特异的补充。在体内使用预靶向技术也可能是结直肠癌患者诊断方面的一项进展,无论是使用(67)Ga和单光子发射计算机断层扫描(SPECT)还是(68)Ga和正电子发射断层扫描(PET)。